Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy

Documenti analoghi

• New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
  di: Godbole, Abhijit M., et al.
  Pubblicazione: (2011)
• CYP17 inhibitors for prostate cancer therapy
  di: Vasaitis, Tadas S., et al.
  Pubblicazione: (2010)
• Mechanism of Androgen Receptor Antagonism by Bicalutamide in the Treatment of Prostate Cancer
  di: Osguthorpe, D.J., et al.
  Pubblicazione: (2011)
• Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer
  di: Norris, John D., et al.
  Pubblicazione: (2017)
• Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
  di: Siddique, Hifzur Rahman, et al.
  Pubblicazione: (2011)